Public Release: 

2018 ICIS-BioLegend William E. Paul Award for Excellence in Cytokine Research

Giorgio Trinchieri, M.D., NIH, National Cancer Institute, Center for Cancer Research

International Cytokine & Interferon Society


IMAGE: Giorgio Trinchieri, M.D., NIH, National Cancer Institute, Center for Cancer Research is the recipient of the 2018 ICIS-BioLegend William E Paul Award for Excellence in Cytokine Research in recognition of... view more 

Credit: International Cytokine & Interferon Society

Giorgio Trinchieri, MD, NIH, National Cancer Institute, Center for Cancer Research is the recipient of the 2018 ICIS-BioLegend William E Paul Award for Excellence in Cytokine Research in recognition of his collective contributions to the field of cytokine biology. "The ICIS is honored to present the BioLegend William E. Paul Award to Dr. Trinchieri this year for his pioneering contributions to our understanding of the role of cytokines in inflammation, immunity, and cancer. His discovery of interleukin-12 provided the link between cells and cytokines of innate immunity with those of adaptive immunity. His cutting-edge research on the interface of inflammation and immunity will continue to provide knowledge that will translate basic science discoveries to clinical therapeutics." said Dr. Nancy Reich Marshall, President of the ICIS.

Dr. Trinchieri is currently the Director of the Cancer and Inflammation Program, an NIH Distinguished Investigator and Head of the Cancer Immunobiology Section. Previously Dr. Trinchieri held positions as Professor and Chair of the Immunology Program at the Wistar institute (1990-1999) in Philadelphia, PA and Director of the Schering Plough Laboratory for Immunological Research in Dardilly, France (1999-2004).

Dr. Trinchieri is internationally recognized for his seminal contributions to the field of cytokine biology. Collectively, his work has led to the characterization of critical elements involved in the interplay between inflammation/innate resistance and adaptive immunity, and in the definition of central roles of cytokines and interferons in the regulation of hematopoiesis, innate resistance and immunity in infections and cancer.

Dr. Trinchieri's work truly defined the area of IL-12 biology and has led to multiple patents for use of IL12 in therapeutics.


For more detailed information

The ICIS-BioLegend William E. Paul Award represents the pinnacle of scientific achievement in cytokine research. The William E. Paul Award is bestowed upon a leading biomedical research scientist who has made outstanding contributions to cytokine research, either in a basic or applied field as demonstrated by publications, oral presentations and consistent scientific advancements in cytokine biology throughout their career, through the generosity of BioLegend. The awardee is selected by the ICIS Awards Committee based on nominations received from the international scientific community. The selection is based on strength and consistency throughout their career of cytokine research publications in peer reviewed journals, contributions to cytokine biology through the publication of reviews and book chapters, long term evidence of presenting their work on cytokine biology to the international community in oral presentations and leadership in the field as demonstrated by organization of cytokine biology meetings and chairing of sessions focused on cytokine biology at national/international meetings.

About ICIS

The International Cytokine and Interferon Society, based in Oradell, NJ and Regensburg, Germany, is a non-profit organization devoted to cytokine, interferon, and chemokine research in the fields of cell biology, molecular biology, biochemistry, and pre-clinical and clinical drug development. The ICIS provides a forum for sharing knowledge and encourages investigations that will lead to the prevention, diagnosis and treatment of diseases that impact humanity. ICIS members' research has led to significant breakthroughs in understanding and treating cancer, inflammatory diseases such as rheumatoid arthritis, viral diseases such as hepatitis and influenza, and autoimmune disorders such as multiple sclerosis and lupus.

Cytokines 2018 will be held 27-30 October, 2018 at the Westin Boston Waterfront in Boston, USA bringing together leading investigators across many different research disciplines in the field of cytokine biology that impact all aspects of medicine. One aim of the meeting is to bridge the gap between the scientists performing basic research on molecular and cellular mechanisms of immune cell activation and function with those working to develop this knowledge into novel therapies.

Abstract Topics:

  • Cytokine regulation
  • Innate immunity
  • Cytokines in Allergy & Th2 Immunity
  • Cytokines in skin inflammatory diseases
  • Mucosal immunity
  • Autoinflammation & Autoimmunity
  • Anti-cytokine therapy
  • T cell differentiation & function
  • Cytokines in cancer development & antitumor immune therapy

Deadline is 1 June for Abstract Submission, Travel Award and/or Young Investigator Award Applications

Contact: Joan Oefner,

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.